1-3 of 3
Garth Nelson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in progress: CAR-T (idecabtagene vicleucel) in advanced myeloma plus iberdomide or usual monitoring (The Alliance A062102 CADMIUM Study)

Free
Sascha Tuchman, Susan Geyer, Garth Nelson, Michael Linden, Aaron Rosenberg, Alison Conlin, Siddhartha Ganguly, Seema Harichand-Herdt, Suzanne Fanning, Destin Carlisle, Rahul Banerjee, Aimaz Afrough, Constantine Mitsiades, Jens Hillengass, Vera Jean Suman, C. Kennedy, Sarah Holstein, Shira Dinner, Peter Voorhees, Saad Usmani
Journal: Blood
Blood (2025) 146 (Supplement 1): 2289.
https://doi.org/10.1182/blood-2025-2289
Published: 2025
Journal Articles

A randomized phase II study of daratumumab, lenalidomide, ixazomib, and dexamethasone in transplant-ineligible or deferred patients with newly diagnosed multiple myeloma: Alliance Foundation Trial 41 (AFT-41)

Free
Andrew Yee, Elizabeth O'Donnell, Omar Nadeem, Garth Nelson, Tanya Wildes, Tondre Buck, Sascha Tuchman, Krishna Ghimire, Sarah Sinclair, Catherine Stewart, Paul Richardson, Saad Usmani, Noopur Raje
Journal: Blood
Blood (2025) 146 (Supplement 1): 4053.
https://doi.org/10.1182/blood-2025-4053
Published: 2025
Journal Articles

Lenalidomide Plus R-CHOP (R2CHOP) in Patients with Follicular Lymphoma: Data from a Phase 1/2 Study

Free
Ayed O. Ayed, MD, Levi Pederson, William R. Macon, MD, Betsy R. Laplant, MS, Craig B. Reeder, MD, James M. Foran, MD, Garth Nelson, Candido E. Rivera, MD, Thomas M. Habermann, MD, Thomas E. Witzig, MD, Grzegorz S. Nowakowski, MD
Journal: Blood
Blood (2016) 128 (22): 5322.
https://doi.org/10.1182/blood.V128.22.5322.5322
Published: 2016